1. Home
  2. GNPX vs HXHX Comparison

GNPX vs HXHX Comparison

Compare GNPX & HXHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

N/A

Current Price

$2.00

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

HXHX

Haoxin Holdings Limited Class A Ordinary Shares

N/A

Current Price

$0.47

Market Cap

7.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GNPX
HXHX
Founded
2009
2003
Country
United States
China
Employees
N/A
85
Industry
Biotechnology: Pharmaceutical Preparations
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
7.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
GNPX
HXHX
Price
$2.00
$0.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
852.6K
2.9M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
76.33
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.96
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.33
52 Week High
$12.97
$2.15

Technical Indicators

Market Signals
Indicator
GNPX
HXHX
Relative Strength Index (RSI) 46.07 43.70
Support Level $1.90 $0.34
Resistance Level $2.51 $0.55
Average True Range (ATR) 0.20 0.04
MACD 0.01 -0.01
Stochastic Oscillator 32.89 16.55

Price Performance

Historical Comparison
GNPX
HXHX

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

Share on Social Networks: